Lipids Extracted from Mycobacterial Membrane and Enveloped PLGA Nanoparticles for Encapsulating Antibacterial Drugs Elicit Synergistic Antimicrobial Response against Mycobacteria-Reference-Cited by-同舟云学术

Lipids Extracted from Mycobacterial Membrane and Enveloped PLGA Nanoparticles for Encapsulating Antibacterial Drugs Elicit Synergistic Antimicrobial Response against Mycobacteria

Published:2024-04-15 Issue:5 Volume:21 Page:2238-2249
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Pu Xueyu¹²³,Wang Yuanyuan¹²³,Wang Xi¹²³,Sang Xiaoqing¹²³,Jiang Miaomiao²^ORCID,Qi DaWei⁴,Zhao Xin⁵⁶,Chen Rong⁵⁶,Li Jianwei⁴^ORCID,Liu Xiang⁵⁶^ORCID,Liu Zhidong²,Yang Jian¹²³^ORCID

Affiliation:

1. Tianjin Key Laboratory of Chinese Medicine Pharmacology. Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China

2. State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China

3. Haihe Laboratory of Modern Chinese Medicine, Tianjin 301617, China

4. Medcity Research Laboratory, University of Turku, Tykistokatu 6, FI-20520 Turku, Finland

5. State Key Laboratory of Medicinal Chemical Biology, Frontiers Science Center for Cell Responses, College of Life Sciences, Nankai University, Tianjin 300071, China

6. Infectious Disease Drug Discovery Institute, Tianjin International Joint Academy of Biotechnology and Medicine, Tianjin 300457, China

Funder

National Natural Science Foundation of China

Science and Technology Project of Haihe Laboratory of Modern Chinese Medicine

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.3c01001

Reference42 articles.

1. Global Tuberculosis Report 2020 – Reflections on the Global TB burden, treatment and prevention efforts

2. New structural classes of antituberculosis agents

3. Antimycobacterial susceptibility evaluation of rifampicin and isoniazid benz-hydrazone in biodegradable polymeric nanoparticles against Mycobacterium tuberculosis H37Rv strain

4. Targeted Intracellular Delivery of Antituberculosis Drugs to Mycobacterium tuberculosis-Infected Macrophages via Functionalized Mesoporous Silica Nanoparticles

5. Macrophage‐Targeted Isoniazid–Selenium Nanoparticles Promote Antimicrobial Immunity and Synergize Bactericidal Destruction of Tuberculosis Bacilli